Downregulation of glial genes involved in synaptic function mitigates Huntington's Disease pathogenesis
- Baylor College of Medicine, United States
- Balor College of Medicine, United States
- Texas Children's Hospital, United States
- Fudan University, China
- Rice University, United States
Abstract
Most research on neurodegenerative diseases has focused on neurons, yet glia help form and maintain the synapses whose loss is so prominent in these conditions. To investigate the contributions of glia to Huntington's disease (HD), we profiled the gene expression alterations of Drosophila expressing human mutant Huntingtin (mHTT) in either glia or neurons and compared these changes to what is observed in HD human and HD mice striata. A large portion of conserved genes are concordantly dysregulated across the three species; we tested these genes in a high-throughput behavioral assay and found that downregulation of genes involved in synapse assembly mitigated pathogenesis and behavioral deficits. To our surprise, reducing dNRXN3 function in glia was sufficient to improve the phenotype of flies expressing mHTT in neurons, suggesting that mHTT's toxic effects in glia ramify throughout the brain. This supports a model in which dampening synaptic function is protective because it attenuates the excitotoxicity that characterizes HD.
Data availability
RNA-sequencing data produced by this study has been deposited in GEO under accession code GSE157287. We have provided source data for all main figures 2, 3,4,5, and 6 as well as for supplemental figures 4,5, and 6. Codes for analyzing gene expression, networks, and Drosophila behavior are provided.
-
RNA-sequencing of Drosophila expressing mutant Huntingtin in neurons or gliaNCBI Gene Expression Omnibus, GSE157287.
-
hESC-based human glial chimeric mice reveal glial differentiation defects in Huntington diseaseNCBI Gene Expression Omnibus, GSE105041.
-
Human cerebellum, frontal cortex [BA4, BA9] and caudate nucleus HD tissue experimentNCBI Gene Expression Omnibus, GSE3790.
Article and author information
Author details
Funding
This work was supported by grants to J.B. from NIH/ NIA (R01AG057339) and CHDI. B.L. is sponsored by Natural Science Foundation of China (31970747, 31601105, 81870990, 81925012). T.O. and M.M. were supported by the NIGMS Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32 GM008307) provided to the Genetics & Genomics Graduate Program at Baylor College of Medicine. A.L. was supported by Baylor College of Medicine Medical Scientist Training Program and the NLM Training Program in Biomedical Informatics and Data Science (T15 LM007093) at the Gulf Coast Consortium. The High Throughput Behavioral Screening core at the Jan and Dan Duncan Neurological Research Institute was supported by generous philanthropy from the Hildebrand family foundation. The project was also supported by a shared Instrumentation grant from the NIH (S10 OD016167) and Baylor College of Medicine IDDRC Grant Number P50HD103555 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development for use of the Microscopy Core facilities, the Cell and Tissue Pathogenesis Core and the RNA In Situ Hybridization Core facility with the expert assistance of Dr. Cecilia Ljungberg. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health.
Copyright
© 2021, Onur et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,523
- views
-
- 554
- downloads
-
- 24
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Downregulation of glial genes involved in synaptic function mitigates Huntington's Disease pathogenesis
eLife 10:e64564.
https://doi.org/10.7554/eLife.64564
Further reading
-
- Computational and Systems Biology
- Genetics and Genomics
Root causal gene expression levels – or root causal genes for short – correspond to the initial changes to gene expression that generate patient symptoms as a downstream effect. Identifying root causal genes is critical towards developing treatments that modify disease near its onset, but no existing algorithms attempt to identify root causal genes from data. RNA-sequencing (RNA-seq) data introduces challenges such as measurement error, high dimensionality and non-linearity that compromise accurate estimation of root causal effects even with state-of-the-art approaches. We therefore instead leverage Perturb-seq, or high-throughput perturbations with single-cell RNA-seq readout, to learn the causal order between the genes. We then transfer the causal order to bulk RNA-seq and identify root causal genes specific to a given patient for the first time using a novel statistic. Experiments demonstrate large improvements in performance. Applications to macular degeneration and multiple sclerosis also reveal root causal genes that lie on known pathogenic pathways, delineate patient subgroups and implicate a newly defined omnigenic root causal model.
-
- Computational and Systems Biology
Artificial intelligence (AI) models have been used to study the compositional regularities of proteins in nature, enabling it to assist in protein design to improve the efficiency of protein engineering and reduce manufacturing cost. However, in industrial settings, proteins are often required to work in extreme environments where they are relatively scarce or even non-existent in nature. Since such proteins are almost absent in the training datasets, it is uncertain whether AI model possesses the capability of evolving the protein to adapt extreme conditions. Antibodies are crucial components of affinity chromatography, and they are hoped to remain active at the extreme environments where most proteins cannot tolerate. In this study, we applied an advanced large language model (LLM), the Pro-PRIME model, to improve the alkali resistance of a representative antibody, a VHH antibody capable of binding to growth hormone. Through two rounds of design, we ensured that the selected mutant has enhanced functionality, including higher thermal stability, extreme pH resistance, and stronger affinity, thereby validating the generalized capability of the LLM in meeting specific demands. To the best of our knowledge, this is the first LLM-designed protein product, which is successfully applied in mass production.
